Loading...
Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation
Clear cell renal cell carcinoma (ccRCC) represents the most common subtype of renal cell carcinoma (RCC). In spite of recent advances in the treatment armamentarium and outcomes with the combined use of immune checkpoint and angiogenesis inhibitors, prediction of responses and selection of patients...
Na minha lista:
| Udgivet i: | J Kidney Cancer VHL |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Codon Publications
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497900/ https://ncbi.nlm.nih.gov/pubmed/32983840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15586/jkcvhl.2020.135 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|